The AmBisome brand, founded in 1989 (United States), from 32 sister brands and 17477 competing brands. AmBisome is owned by Gilead Sciences, listed on the stock exchange of New York AmBisome belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Gilead Sciences
(AmBisome)
over 5 years*
USD 65.55